Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

FREE TO READ] Critics say fragmented ownership, weak culture and a fixation on financial results have harmed innovation ...

The Genesis Prize Foundation’s Stan Polovets highlights the impact of Thessaloniki's Holocaust Museum and global efforts ...

Bourla said he sees the potential to build programs ... which appears to have a particular emphasis on changing U.S. food policy. Gilead CEO Daniel O'Day told CNBC that the company's work ...

Bourla said the experts were helping Pfizer "make better and more sound decisions," and the company could start a late-stage study of its drug, danuglipron, in the second half of this year.

Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla. In his first term, Trump championed the $18 billion Operation Warp Speed ...

Speaking to the Financial Times, Albert Bourla pointed out that during two days of grilling from US senators last week, Kennedy, Donald Trump’s nominee for US health secretary, “was very ...